| __timestamp | Alnylam Pharmaceuticals, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 621276000 |
| Thursday, January 1, 2015 | 41097000 | 737887000 |
| Friday, January 1, 2016 | 47159000 | 907234000 |
| Sunday, January 1, 2017 | 76545000 | 1071860000 |
| Monday, January 1, 2018 | 73106000 | 1175948000 |
| Tuesday, January 1, 2019 | 194688000 | 1344582000 |
| Wednesday, January 1, 2020 | 414801000 | 1336183000 |
| Friday, January 1, 2021 | 704143000 | 1375760000 |
| Saturday, January 1, 2022 | 868601000 | 1612370000 |
| Sunday, January 1, 2023 | 1517886000 | 1842161000 |
| Monday, January 1, 2024 | 1924873000 | 2273680000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, Alnylam Pharmaceuticals and BioMarin Pharmaceutical have carved distinct paths over the past decade. From 2014 to 2023, BioMarin consistently outperformed Alnylam in gross profit, with BioMarin's figures peaking at approximately 1.84 billion in 2023, a 196% increase from 2014. Alnylam, however, showcased a remarkable growth trajectory, with its gross profit surging by over 2,900% during the same period, reaching around 1.52 billion in 2023. This impressive growth highlights Alnylam's strategic advancements and market penetration. While BioMarin's steady climb underscores its established market presence, Alnylam's rapid ascent signals its emerging influence in the biotech sector. As these companies continue to innovate, their financial trajectories offer a fascinating glimpse into the evolving landscape of pharmaceutical innovation.
Gross Profit Trends Compared: Johnson & Johnson vs BioMarin Pharmaceutical Inc.
AstraZeneca PLC and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Sanofi vs Alnylam Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing GSK plc and BioMarin Pharmaceutical Inc.
Alnylam Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Ascendis Pharma A/S
Alnylam Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Biogen Inc. vs BioMarin Pharmaceutical Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or BioMarin Pharmaceutical Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown